Apollo Endosurgery, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APEN research report →
Companywww.apolloendo.com
Apollo Endosurgery, Inc. , a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope.
- CEO
- Charles S. McKhann
- IPO
- 2005
- Employees
- 202
- HQ
- Austin, TX, US
Price Chart
Valuation
- Market Cap
- $579.72M
- P/E
- -10.20
- P/S
- 7.54
- P/B
- 12.47
- EV/EBITDA
- -18.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 55.20%
- Op Margin
- -36.20%
- Net Margin
- -51.84%
- ROE
- -84.92%
- ROIC
- -30.59%
Growth & Income
- Revenue
- $76.86M · 22.01%
- Net Income
- $-39,839,000 · -61.41%
- EPS
- $-0.98 · -19.51%
- Op Income
- $-27,822,000
- FCF YoY
- -113.75%
Performance & Tape
- 52W High
- $10.30
- 52W Low
- $3.49
- 50D MA
- $9.94
- 200D MA
- $7.73
- Beta
- 2.32
- Avg Volume
- 1.33M
Get TickerSpark's AI analysis on APEN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 4, 23 | McGaughy R Kent Jr | sell | 38,667 |
| Apr 4, 23 | McGaughy R Kent Jr | sell | 400,675 |
| Apr 4, 23 | CPMG Inc | sell | 400,675 |
| Apr 4, 23 | BARR JOHN R | sell | 29,317 |
| Apr 4, 23 | BARR JOHN R | sell | 19,333 |
| Apr 4, 23 | BARR JOHN R | sell | 16,536 |
| Apr 4, 23 | BARR JOHN R | sell | 44,082 |
| Apr 4, 23 | BARR JOHN R | sell | 5,271 |
| Apr 4, 23 | Bankes Jeannette | sell | 9,533 |
| Apr 4, 23 | Bankes Jeannette | sell | 19,333 |
Our APEN Coverage
We haven't published any research on APEN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate APEN Report →